These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 27993684)

  • 21. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo.
    Guan H; Wang M; Yu S; Wang C; Chen Q; Chen Y; Zhang W; Fan J
    J Pharm Sci; 2024 Oct; 113(10):3045-3053. PubMed ID: 39094942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
    Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
    Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of poly (acrylic acid) modified mesoporous silica nanoparticles as pH response carrier for β-elemene self-micro emulsifying.
    Yan B; Wang Y; Ma Y; Zhao J; Liu Y; Wang L
    Int J Pharm; 2019 Dec; 572():118768. PubMed ID: 31669556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MOF Capacitates Cyclodextrin to Mega-Load Mode for High-Efficient Delivery of Valsartan.
    Zhang W; Guo T; Wang C; He Y; Zhang X; Li G; Chen Y; Li J; Lin Y; Xu X; Wu L; Zhang S; Zhang J
    Pharm Res; 2019 Jun; 36(8):117. PubMed ID: 31161271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability.
    Vuppalapati L; Cherukuri S; Neeli V; Yeragamreddy PR; Kesavan BR
    Curr Drug Deliv; 2016; 13(1):143-57. PubMed ID: 26205900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol.
    Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W
    Molecules; 2019 May; 24(9):. PubMed ID: 31067732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-Functionalized Mesoporous Silica Nanoparticles for Celecoxib Delivery: Amine Grafting and Imidazolyl PEI Gatekeepers for Enhanced Loading and Controlled Release with Reduced Toxicity.
    Mudhakir D; Sadaqa E; Permana Z; Mumtazah JE; Zefrina NF; Xeliem JN; Hanum LF; Kurniati NF
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carrier particle mediated stabilization and isolation of valsartan nanoparticles.
    Kumar A; Davern P; Hodnett BK; Hudson SP
    Colloids Surf B Biointerfaces; 2019 Mar; 175():554-563. PubMed ID: 30579056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, Characterization, and Evaluation of Mesoporous Silica Nanoparticles in Enhancing Oral Bioavailability of Poorly Water-Soluble Drugs.
    Zhang H; Zuo F; Wang B; Qiu X
    Curr Drug Deliv; 2024; 21(11):1529-1536. PubMed ID: 38310438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel IMB16-4 Compound Loaded into Silica Nanoparticles Exhibits Enhanced Oral Bioavailability and Increased Anti-Liver Fibrosis In Vitro.
    Niu X; Wang X; Niu B; Li G; Yang X; Wang Y; Li G
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.